News and Announcements
Altech Chemicals Ltd – Capital Raising Update & Share Purchase Plan
- Published March 22, 2016 2:24PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
21st March 2016, ASX Announcement
Altech Chemicals Limited (Altech/the Company) (ASX: ATC) advises that further to the suspension of the trading of its securities on the ASX pre-open this morning, Perth stockbroking firm DJ Carmichael Pty Ltd is co-ordinating a placement of fully paid ordinary shares of the Company to a variety of professional and sophisticated investors (the Placement). It is the intention of the Company to announce details of the Placement pre-open on Wednesday 23 March 2016.
In addition to the Placement, the Company intends to conduct a Share Purchase Plan (SPP), whereby existing shareholder of the Company can subscribe to a maximum of $15,000 of new shares, at the same price as the Placement shares. The Company intends to also announce details of the SPP on 23 March 2016.
To view the full article please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
